USA flag logo/image

An Official Website of the United States Government

Polycrystalline LuAlO3:Ce Scintillators for PET Applications

Award Information

Department of Energy
Award ID:
Program Year/Program:
2006 / SBIR
Agency Tracking Number:
Solicitation Year:
Solicitation Topic Code:
Solicitation Number:
Small Business Information
Technology Assessment & Transfer, Inc.
133 Defense Highway, Suite 212 Annapolis, MD 21401-
View profile »
Woman-Owned: Yes
Minority-Owned: No
HUBZone-Owned: No
Phase 1
Fiscal Year: 2006
Title: Polycrystalline LuAlO3:Ce Scintillators for PET Applications
Agency: DOE
Contract: DE-FG02-06ER84438
Award Amount: $99,935.00


Although PET imaging, a technology used in medicine, has advanced rapidly in recent decades, further advances will depend on improvements in the scintillator materials. New materials have been identified, but they are unstable under the conditions used for single crystal growth, leading frequently to poor quality. LuAlO3:Ce appears to be an excellent candidate for PET applications, but the challenges associated with growing single crystals of this material make the task of commercialization and optimization especially challenging. This project will utilize powder synthesis and ceramic processing to develop transparent polycrystalline scintillators from LuAlO3:Ce. In Phase I, sol-gel synthesis will be used to produce comositionally homogeneous powders of LuAlO3:Ce. These powders will be formed into green bodies and sintered to transparency. The properties of these scintillators will be evaluated and compared against the single crystal materials currently used for PET. The scintillation characterisics of the powders will be evaluated as a fast screening tool for material optimization, through adjustments of dopant and co-dopant additions. Commercial Applications and Other Benefits as described by the Applicant: Transparent ceramic scintillators would be expected to benefit the health care and pharmaceutical industries, enhancing the spatial resolution of PET imaging. Ceramic scintillators would be less expensive and easier to produce than single crystals of the same materials. Ultimately, these advances would have a beneficial impact on the early identification of diseases such as cancer, which is less costly to treat when diagnosed early. In addition, the pharmaceutical industry may benefit by shortening clinical and pre-clinical trials, through better correlation between small animal and human studies

Principal Investigator:

Eric A. Gulliver

Business Contact:

Sharon Fehrenbacher
Small Business Information at Submission:

Technology Assessment and Transfer, Inc.
133 Defense Highway Suite 212 Millersville, MD 21401

EIN/Tax ID: 521253097
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No